{"count": 99, "results": [{"_id": "35557834", "pmid": 35557834, "pmcid": "PMC9087341", "title": "Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases", "journal": "Front Aging Neurosci", "authors": ["Du MR", "Gao QY", "Liu CL", "Bai LY", "Li T", "Wei FL"], "date": "2022-04-26T00:00:00Z", "doi": "10.3389/fnagi.2022.838173", "meta_date_publication": "2022", "meta_volume": "14", "meta_issue": "", "meta_pages": "838173", "score": 50279.867, "text_hl": "Exploring the Pharmacological Potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@Neurodegenerative Diseases@@@", "citations": {"NLM": "Du MR, Gao QY, Liu CL, Bai LY, Li T, Wei FL. Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases Front Aging Neurosci. 2022;14():838173. PMID: 35557834", "BibTeX": "@article{35557834, title={Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases}, author={Du MR and Gao QY and Liu CL and Bai LY and Li T and Wei FL}, journal={Front Aging Neurosci}, volume={14}, pages={838173}}"}}, {"_id": "40283923", "pmid": 40283923, "title": "Overview of Metformin and Neurodegeneration: A Comprehensive Review.", "journal": "Pharmaceuticals (Basel)", "authors": ["Kruczkowska W", "Gałęziewska J", "Buczek P", "Płuciennik E", "Kciuk M", "Śliwińska A"], "date": "2025-03-28T00:00:00Z", "doi": "10.3390/ph18040486", "meta_date_publication": "2025 Mar 28", "meta_volume": "18", "meta_issue": "4", "meta_pages": "", "score": 50276.26, "text_hl": "Overview of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@Neurodegeneration@@@: A Comprehensive Review.", "citations": {"NLM": "Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A. Overview of Metformin and Neurodegeneration: A Comprehensive Review. Pharmaceuticals (Basel). 2025 Mar 28;18(4):. PMID: 40283923", "BibTeX": "@article{40283923, title={Overview of Metformin and Neurodegeneration: A Comprehensive Review.}, author={Kruczkowska W and Gałęziewska J and Buczek P and Płuciennik E and Kciuk M and Śliwińska A}, journal={Pharmaceuticals (Basel)}, volume={18}, number={4}}"}}, {"_id": "38139841", "pmid": 38139841, "pmcid": "PMC10748332", "title": "Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders", "journal": "Pharmaceuticals (Basel)", "authors": ["Isop LM", "Neculau AE", "Necula RD", "Kakucs C", "Moga MA", "Dima L"], "date": "2023-12-11T00:00:00Z", "doi": "10.3390/ph16121714", "meta_date_publication": "2023 Dec 11", "meta_volume": "16", "meta_issue": "12", "meta_pages": "", "score": 50273.957, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@Neurodegenerative Disorders@@@", "citations": {"NLM": "Isop LM, Neculau AE, Necula RD, Kakucs C, Moga MA, Dima L. Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders Pharmaceuticals (Basel). 2023 Dec 11;16(12):. PMID: 38139841", "BibTeX": "@article{38139841, title={Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders}, author={Isop LM and Neculau AE and Necula RD and Kakucs C and Moga MA and Dima L}, journal={Pharmaceuticals (Basel)}, volume={16}, number={12}}"}}, {"_id": "32719079", "pmid": 32719079, "pmcid": "PMC7390234", "title": "Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis", "journal": "BMJ Open Diabetes Res Care", "authors": ["Ping F", "Jiang N", "Li Y"], "date": "2020-07-01T00:00:00Z", "doi": "10.1136/bmjdrc-2020-001370", "meta_date_publication": "2020 Jul", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50271.03, "text_hl": "Association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@neurodegenerative diseases@@@ of observational studies: systematic review and meta-analysis", "citations": {"NLM": "Ping F, Jiang N, Li Y. Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis BMJ Open Diabetes Res Care. 2020 Jul;8(1):. PMID: 32719079", "BibTeX": "@article{32719079, title={Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis}, author={Ping F and Jiang N and Li Y}, journal={BMJ Open Diabetes Res Care}, volume={8}, number={1}}"}}, {"_id": "39201569", "pmid": 39201569, "title": "Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?", "journal": "Int J Mol Sci", "authors": ["Papini N", "Giussani P", "Tringali C"], "date": "2024-08-15T00:00:00Z", "doi": "10.3390/ijms25168884", "meta_date_publication": "2024 Aug 15", "meta_volume": "25", "meta_issue": "16", "meta_pages": "", "score": 50270.56, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Lysosomal Targeting: A Novel Aspect to @CHEMICAL_Beryllium @CHEMICAL_MESH:D001608 @@@Be@@@ Investigated for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Repurposing in @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@Neurodegenerative Diseases@@@?", "citations": {"NLM": "Papini N, Giussani P, Tringali C. Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases? Int J Mol Sci. 2024 Aug 15;25(16):. PMID: 39201569", "BibTeX": "@article{39201569, title={Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?}, author={Papini N and Giussani P and Tringali C}, journal={Int J Mol Sci}, volume={25}, number={16}}"}}, {"_id": "34671273", "pmid": 34671273, "pmcid": "PMC8521008", "title": "Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?", "journal": "Front Physiol", "authors": ["Shoshan-Barmatz V", "Anand U", "Nahon-Crystal E", "Di Carlo M", "Shteinfer-Kuzmine A"], "date": "2021-10-04T00:00:00Z", "doi": "10.3389/fphys.2021.730048", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "730048", "score": 50268.85, "text_hl": "Adverse Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ From @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ to @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@, @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Cancer@@@, @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@Neurodegenerative Diseases@@@, and Aging: Is @GENE_VDAC1 @GENE_7416 @@@VDAC1@@@ a Common Target?", "citations": {"NLM": "Shoshan-Barmatz V, Anand U, Nahon-Crystal E, Di Carlo M, Shteinfer-Kuzmine A. Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Front Physiol. 2021;12():730048. PMID: 34671273", "BibTeX": "@article{34671273, title={Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?}, author={Shoshan-Barmatz V and Anand U and Nahon-Crystal E and Di Carlo M and Shteinfer-Kuzmine A}, journal={Front Physiol}, volume={12}, pages={730048}}"}}, {"_id": "33716063", "pmid": 33716063, "title": "Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.", "journal": "Life Sci", "authors": ["Sharma S", "Nozohouri S", "Vaidya B", "Abbruscato T"], "date": "2021-06-01T00:00:00Z", "doi": "10.1016/j.lfs.2021.119343", "meta_date_publication": "2021 Jun 1", "meta_volume": "274", "meta_issue": "", "meta_pages": "119343", "score": 50262.47, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to treat @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@age-related neurodegenerative disorders@@@ and @DISEASE_Cerebral_Infarction @DISEASE_MESH:D002544 @@@ischemic stroke@@@.", "citations": {"NLM": "Sharma S, Nozohouri S, Vaidya B, Abbruscato T. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke. Life Sci. 2021 Jun 1;274():119343. PMID: 33716063", "BibTeX": "@article{33716063, title={Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.}, author={Sharma S and Nozohouri S and Vaidya B and Abbruscato T}, journal={Life Sci}, volume={274}, pages={119343}}"}}, {"_id": "36484892", "pmid": 36484892, "pmcid": "PMC9733765", "title": "Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study", "journal": "Mol Biomed", "authors": ["Du Y", "Zhu YJ", "Zhou YX", "Ding J", "Liu JY"], "date": "2022-12-09T00:00:00Z", "doi": "10.1186/s43556-022-00108-w", "meta_date_publication": "2022 Dec 9", "meta_volume": "3", "meta_issue": "1", "meta_pages": "41", "score": 50259.906, "text_hl": "However, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also results in some adverse effects, such as @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal complaints@@@, @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@vitamin B12 deficiency@@@ and @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@neurodegenerative disease@@@. ", "citations": {"NLM": "Du Y, Zhu YJ, Zhou YX, Ding J, Liu JY. Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study Mol Biomed. 2022 Dec 9;3(1):41. PMID: 36484892", "BibTeX": "@article{36484892, title={Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study}, author={Du Y and Zhu YJ and Zhou YX and Ding J and Liu JY}, journal={Mol Biomed}, volume={3}, number={1}, pages={41}}"}}, {"_id": "37093496", "pmid": 37093496, "title": "Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis.", "journal": "Pharmacol Rep", "authors": ["Karami F", "Jamaati H", "Coleman-Fuller N", "Zeini MS", "Hayes AW", "Gholami M", "Salehirad M", "Darabi M", "Motaghinejad M"], "date": "2023-06-01T00:00:00Z", "doi": "10.1007/s43440-023-00469-1", "meta_date_publication": "2023 Jun", "meta_volume": "75", "meta_issue": "3", "meta_pages": "511-543", "score": 50258.926, "text_hl": "Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ neuroprotective against @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@-induced @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@neurodegeneration@@@? ", "citations": {"NLM": "Karami F, Jamaati H, Coleman-Fuller N, Zeini MS, Hayes AW, Gholami M, Salehirad M, Darabi M, Motaghinejad M. Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis. Pharmacol Rep. 2023 Jun;75(3):511-543. PMID: 37093496", "BibTeX": "@article{37093496, title={Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis.}, author={Karami F and Jamaati H and Coleman-Fuller N and Zeini MS and Hayes AW and Gholami M and Salehirad M and Darabi M and Motaghinejad M}, journal={Pharmacol Rep}, volume={75}, number={3}, pages={511-543}}"}}, {"_id": "34510763", "pmid": 34510763, "pmcid": "PMC8611779", "title": "A high fat, sugar, and salt Western diet induces motor-muscular and sensory dysfunctions and neurodegeneration in mice during aging: Ameliorative action of metformin", "journal": "CNS Neurosci Ther", "authors": ["Hong S", "Nagayach A", "Lu Y", "Peng H", "Duong QA", "Pham NB", "Vuong CA", "Bazan NG"], "date": "2021-12-01T00:00:00Z", "doi": "10.1111/cns.13726", "meta_date_publication": "2021 Dec", "meta_volume": "27", "meta_issue": "12", "meta_pages": "1458-1471", "score": 50258.926, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ also attenuates aging-associated @<m>DISEASE_Neurodegenerative_Diseases</m> @DISEASE_MESH:D019636 @@@neurodegeneration@@@. ", "citations": {"NLM": "Hong S, Nagayach A, Lu Y, Peng H, Duong QA, Pham NB, Vuong CA, Bazan NG. A high fat, sugar, and salt Western diet induces motor-muscular and sensory dysfunctions and neurodegeneration in mice during aging: Ameliorative action of metformin CNS Neurosci Ther. 2021 Dec;27(12):1458-1471. PMID: 34510763", "BibTeX": "@article{34510763, title={A high fat, sugar, and salt Western diet induces motor-muscular and sensory dysfunctions and neurodegeneration in mice during aging: Ameliorative action of metformin}, author={Hong S and Nagayach A and Lu Y and Peng H and Duong QA and Pham NB and Vuong CA and Bazan NG}, journal={CNS Neurosci Ther}, volume={27}, number={12}, pages={1458-1471}}"}}]}